Showing results (241-250 of 831) with videos related to
Sort By:
Pageof 84
Journal of Nanobiotechnology|May 10, 2007
Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosisPriyabrata Mukherjee, Resham Bhattacharya, Nancy Bone, et al.British Journal of Haematology|June 6, 2003
T-large granular lymphocyte lymphoproliferative disorder: expression of CD26 as a marker of clinically aggressive disease and characterization of marrow inhibitionNam H Dang, Ugur Aytac, Kazuya Sato, et al.International Journal of Cancer|March 1, 2021
Aspirin and other nonsteroidal anti-inflammatory drugs, statins and risk of non-Hodgkin lymphomaMark Liebow, Melissa C Larson, Carrie A Thompson, et al.Leukemia Research|January 22, 2005
Fluorescent-labeled DNA probes applied to novel biological aspects of B-cell chronic lymphocytic leukemiaStephanie R Fink, Sarah F Paternoster, Stephanie A Smoley, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2024
Aberrantly Expressed Mitochondrial Lipid Kinase, AGK, Activates JAK2-Histone H3 Axis and BCR Signal: A Mechanistic Study with Implication in CLL TherapyMurali K Mamidi, Sutapa Sinha, Mariana T Mendez, et al.American Journal of Hematology|April 3, 2016
Relationship of blood monocytes with chronic lymphocytic leukemia aggressiveness and outcomes: a multi-institutional studyDaphne R Friedman, Alexander B Sibley, Kouros Owzar, et al.Cancer|February 27, 2010
Pentostatin and rituximab therapy for previously untreated patients with B-cell chronic lymphocytic leukemiaNeil E Kay, Wenting Wu, Brian Kabat, et al.Cancer|September 2, 2008
Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximabClive S Zent, Timothy G Call, Tait D Shanafelt, et al.The Journal of Clinical Investigation|December 8, 2007
Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patientsRenee C Tschumper, Susan M Geyer, Megan E Campbell, et al.Acta Haematologica|September 26, 2023
Evidence-Based Management of Chronic Lymphocytic Leukemia: Consensus Statements from the Gulf RegionSalem H Alshemmari, Mustaqeem A Siddiqui, Ramesh Pandita, et al.Pageof 84